Find Faculty
Home>Find Faculty>Aikaterini Kompoliti, MD

Aikaterini Kompoliti, MD

Katie Kompoliti, MD
Director, Movement Disorders Fellowship Program
Professor, Department of Neurological Sciences, RUSH Medical College
Educational Director, Section of Movement Disorders, Department of Neurological Sciences
Education

MD, University of Patras Medical School, Greece
Neurology residency, McGaw Medical Center of Northwestern University
Movement disorders fellowship, Rush University Medical Center

Research Areas

Kompoliti is active in clinical research investigating novel medications and interventions to treat Parkinson's disease, Tourette syndrome, functional movement disorders, tremor and dystonia

Contact Info:

1725 W. Harrison St.
Suite 755
Chicago, IL 60612
Phone: (312) 563-2900
Fax: (312) 942-2280
Links:
Biography

Aikaterini (Katie) Kompoliti, MD, was born in Greece and completed her early education there, including medical school. After graduating from the University of Patras Medical School, Greece, she pursued her interest in neuroscience by completing a residency in neurology at Northwestern University, Chicago. Upon completion of her residency she held a fellowship in movement disorders at Rush University Medical Center, Chicago. Following her fellowship, she became a faculty member in movement disorders in the Department of Neurological Sciences at Rush University Medical Center where she is currently professor of neurology. She is the author and coauthor of numerous publications. Her clinical interests as a principal investigator have focused on several therapeutic areas including studies to evaluate the safety and efficacy of new compounds to treat Parkinson’s disease, Tourette syndrome, functional movement disorders and dystonia. Furthermore, she is the educational director of the section of movement disorders and the director of the movement disorders fellowship at Rush University Medical Center.

Honors and Activities

Member, National Medical Advisory Board for the Tourette Association of America, 2001- 2014

Travel fellowship, 121st Annual Meeting of the American Neurological Association, 1996

Publications

http://www.ncbi.nlm.nih.gov/pubmed/?term=Kompoliti%20K%5BAuthor%5D&cauthor=true&cauthor_uid=26807330

Grants

TV50717-CNS-30060
Nuvelution TS Pharma
Principal Investigator
A Well-Controlled, Fixed-Dose Study of TEV‑50717 (Deutetrabenazine) for the Treatment of Tics Associated with Tourette syndrome

TV50717-CNS-30047
Nuvelution TS Pharma
Principal Investigator
An Open-Label, Long-Term Safety Study Including a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period of TEV-50717 (deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents

P2B001/003
Pharma Two B Ltd.
Principal Investigator
A Phase 3, Twelve-week, Multi-Center, Multinational, Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Determine the Efficacy, Safety and Tolerability of P2B001 Once Daily Compared to its Individual Components in Subjects With Early Parkinson’s Disease and to a Calibration Arm of Pramipexole ER

Revance
Sub-Investigator
A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia

RESTORE
Lundbeck
Principal Investigator
A clinical study of patients with symptomatic neurogenic orthostatic hypotension to assess sustained effects of dRoxidopa therapy